LIDIA NAVARRO: Open Payments
NPI 1417428657 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 66 payments from 19 companies in 2025. Trend: 2023 $1,531 · 2024 $1,604 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $401 |
| ABBVIE INC. | 12 | $200 |
| Organon LLC | 9 | $123 |
| Arcutis Biotherapeutics, Inc. | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| Genentech USA, Inc. | 3 | $90 |
| LEO Pharma Inc. | 3 | $74 |
| UCB, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $38 |
| Botanix SB Inc | 2 | $37 |
Products named: COSENTYX, XOLAIR, RINVOQ, VTAMA, Zoryve, Sotyktu, SKYRIZI, Rhapsido.
Industry payments across AZ — which companies pay providers there.
